Condiciones mdicas coexistentes: La presencia de enfermedad cardiovascular, enfermedad renal crnica, retinopata diabtica, o antecedentes de pancreatitis puede influir tanto en la necesidad como en la seguridad del uso prolongado
All references to use relate strictly to non-clinical, laboratory-based research and investigation
CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes
Semaglutide has robust clinical data behind it
Food and Drug Administration approved Novo Nordisks weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly
This widespread distribution has prompted research into potential effects beyond glucose control, including neuroprotective and cognitive benefits